Anti-Snoring Market - Growth, Trends, COVID-19 Impact, and Forecast (2021 - 2026)

The Anti-Snoring Market is Segmented by Treatment Technique (Device Types (Mandibular Advancement Devices (MAD), Tongue Stabilizing Devices (TSD), Continuous Positive Airway Pressure (CPAP) Devices, and Other Device Types) and Surgical Procedure (Uvulopalatopharyngoplasty (UPPP), Somnoplasty, Pillar Procedure, Tonsillectomy, Radiofrequency Palatoplasty, and Other Surgical Procedures)), and Geography (North America, Europe, Asia-Pacific, Middle-East and Africa, South America). The Report Offers Value (in USD million) for the Above-mentioned Segments.

Market Snapshot

anti snoring treatment market
Study Period: 2018 - 2026
Base Year: 2020
Fastest Growing Market: Asia Pacific
Largest Market: North America
CAGR: 10.6 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

The global anti-snoring market is expected to register a CAGR of nearly 10.60% during the forecast period.

As per a study titled, ''A systematic review of COVID-19 and obstructive sleep apnoea'', published in September 2020, obstructive sleep apnea may increase the risk of morbidity and mortality associated with COVID-19. Thus, such instances are expected to positively impact the demand for anti-snoring devices.

An increase in obesity and the geriatric population, increasing smoking and alcohol consumption, technological advancements in anti-snoring devices, and increased awareness among the people are the key factors responsible for the growth of the market.

Weight gain is a major contributor to the habit of snoring because the peculiarities in weight gain affect the elderly population. According to a study titled, ''Obesity Prevalence in the Long-Term Future in 18 European Countries and in the USA'', published in October 2020, obesity is expected to reach maximum levels between the year 2030 and 2052 among men and among women in the year 2026 and 2054. The Netherlands, the United States, the United Kingdom, and Switzerland are likely to hit these maximum levels first. Thus, this rising burned of obesity among people is expected to boost the market growth over the forecast period.

Furthermore, the increasing geriatric population is also expected to contribute tremendously to market growth. As per the World Ageing Population report, in 2019, about 702.9 million people living were aged 65 years and above, and this number is expected to reach 1,548.9 million by the year 2050. Thus, the aforementioned factors indicate that the increasing geriatric population and the rise in obesity are among the major factors for the growth of the anti-snoring market globally.

Scope of the Report

Anti-snoring treatment devices are defined as the equipment used to prevent snoring, which include mandibular advancement devices (MAD), tongue stabilizing devices (TSD), continuous positive airway pressure (CPAP) devices, and nasal devices, among others. Snoring is simply the sound of resistance and turbulence in the upper airway. Contrary to popular belief, the sound of snoring does not come from the nose; instead, snoring starts in the back of the airway. Behind the tongue, the oropharynx may become constricted during sleep. During sleep, the muscles keep the upper airway open, and the patient relaxes. This is more prominent during REM sleep or dream sleep when muscles are most relaxed. As the airway gets smaller, air turbulence increases. The soft tissues in the back of the throat vibrate, which causes the snoring sound. The anti-snoring market is segmented by treatment technique (device types (mandibular advancement devices (MAD), tongue stabilizing devices (TSD), continuous positive airway pressure (CPAP) devices, and other device types) and surgical procedure (uvulopalatopharyngoplasty (UPPP), somnoplasty, pillar procedure, tonsillectomy, radiofrequency palatoplasty, and other surgical procedures)), and Geography (North America, Europe, Asia-Pacific, Middle-East and Africa, and South America). The report offers the value (in USD million) for the above segments, and Geography (North America, Europe, Asia-Pacific, Middle-East and Africa, and South America). The report offers the value (in USD million) for the above segments.

By Treatment Technique
By Device Types
Mandibular Advancement Devices (MAD)
Tongue Stabilizing Devices (TSD)
Continuous Positive Airway Pressure (CPAP) Devices
Other Device Types
By Surgical Procedure
Uvulopalatopharyngoplasty (UPPP)
Somnoplasty
Pillar Procedure
Tonsillectomy
Radiofrequency Palatoplasty
Other Surgical Procedures
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle-East and Africa
GCC
South Africa
Rest of Middle-East and Africa
South America
Brazil
Argentina
Rest of South America

Report scope can be customized per your requirements. Click here.

Key Market Trends

The Continuous Positive Airway Pressure (CPAP) Devices Sub-segment is Expected to Hold the Largest Market Share in the Devices Segment

In the devices segment of the anti-snoring market, the continuous positive airway pressure (CPAP) devices sub-segment is believed to have the largest market size. Amidst this pandemic situation, the demand for CPAP machines and masks is expected to rise since CPAP devices have shown beneficial effects on managing the symptoms of COVID-19, such as ease of breathing. As per a study titled ''CPAP management of COVID-19 respiratory failure: a first quantitative analysis from an inpatient service evaluation'', in 2020, CPAP was found to be a potential tool in the treatment of early-stage COVID-19 patients.

Continuous positive airway pressure (CPAP) devices are used in airway blockages to open up the blocked airways by pushing air into them. The CPAP has a pump that controls the air pressure in the system and consists of a tube carrying air toward the mask attached to the nose and mouth. CPAP devices help ease the functioning of the airway and help the person get a night of sound sleep, increasing their demand.

The companies are constantly engaged in the development of CPAP products via product innovation, mergers, acquisition, etc., to grow their presence in the market. This is expected to accelerate the market growth. For instance, in September 2020, CPAP Store USA, one of the pioneers in CPAP machines, introduced its own CPAP Store USA brand. It is a retail store that will be selling its products, including CPAP wipes, CPAP tubing, CPAP Filters, Chinstraps, CPAP machine travel bags and backpacks, and others.

In June 2019, InnAccel introduced SAANS, a CPAP system in the market. It is the world’s first infrastructure-independent, portable, and neonatal CPAP system that provides constant air flow, preventing the airway from collapsing. Also, it eliminates the vibration of tissue that causes snoring. Hence, CPAP devices are expected to experience growth over the forecast period.

Estimated Number (in millions) of Adults Aged 65 years and Above, Globally, 2019 & 2050

North America Dominates the Market and is Expected to do Same During the Forecast Period

North America currently dominates the anti-snoring market, and it is expected to continue its stronghold for a few more years. With the emergence of COVID-19, the market is expected to observe a positive impact. The study published in the American Journal of Respiratory and Critical Care Medicine, 2020, identified sleep apnea as one of the risk factors among COVID-19 patients. Such studies indicate the need for anti-snoring devices among these patients, as snoring is often associated with sleep apnea.

According to the data of Sleep Foundation, in the United States, in 2019, about 57% of the men and 40% of the women were living with the snoring condition. Furthermore, the rising obese population and the elderly population are also expected to fuel the market studied. According to the Centre for Disease Control and Prevention, 2019, the United States obesity rate was accounted to be approximately 42.4%, an increase of 26% since 2008. Thus, the rising patient population is boosting the regional market growth.

However, owing to new technologies that are constantly being developed pertaining to the market, the diagnosis of these snoring diseases has been effective, and treatments are proving to be more helpful to patients. Thus, the rising awareness among patients regarding the effectiveness of anti-snoring devices and surgeries, and the easy availability of advanced detecting procedures across the world, are resulting in the increased demand for anti-snoring devices and surgeries.

Anti-Snoring Market - Growth Rate by Region

Competitive Landscape

The anti-snoring market is majorly fragmented with several major players. In terms of market share, a few of the major players currently dominate the market. However, with technological advancement and product innovation, mid-size to smaller companies are increasing their market presence by introducing new ingredients at lower prices. Companies, like Fisher & Paykel Healthcare Limited, Koninklijke Philips NV, ResMed, ASF Medical GmbH (Tomed GmbH), and Apnea Sciences, hold a substantial market share in the global anti-snoring market.

Recent Developments

  • In February 2021, the United States Food and Drug Administration (US FDA) approved the commercialization of a prescription-only anti-snoring device, ''eXciteOSA'', developed by Rotech Healthcare. It delivers electrical muscle stimulation via a mouthpiece that is placed around the tongue.
  • In September 2020, ResMed Inc. introduced the ''AirTouch N20 CPAP'', a nasal mask featured with a memory foam cushion. It is based on the company's patented UltraSoft memory foam cushion technology.

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Assumptions and Market Definition

    2. 1.2 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Increase in Obesity and Geriatric Population

      2. 4.2.2 Increasing Smoking and Alcohol Consumption

      3. 4.2.3 Technological Advancements in Anti-Snoring Devices

      4. 4.2.4 Increased Awareness in the Developed Markets

    3. 4.3 Market Restraints

      1. 4.3.1 High Costs of Custom-made Oral Devices

      2. 4.3.2 Poor Efficacy and Lack of Scientific Validation of the Anti-snoring Devices

      3. 4.3.3 Social Stigma Associated with Snoring

    4. 4.4 Porter's Five Forces Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 By Treatment Technique

      1. 5.1.1 By Device Types

        1. 5.1.1.1 Mandibular Advancement Devices (MAD)

        2. 5.1.1.2 Tongue Stabilizing Devices (TSD)

        3. 5.1.1.3 Continuous Positive Airway Pressure (CPAP) Devices

        4. 5.1.1.4 Other Device Types

      2. 5.1.2 By Surgical Procedure

        1. 5.1.2.1 Uvulopalatopharyngoplasty (UPPP)

        2. 5.1.2.2 Somnoplasty

        3. 5.1.2.3 Pillar Procedure

        4. 5.1.2.4 Tonsillectomy

        5. 5.1.2.5 Radiofrequency Palatoplasty

        6. 5.1.2.6 Other Surgical Procedures

    2. 5.2 Geography

      1. 5.2.1 North America

        1. 5.2.1.1 United States

        2. 5.2.1.2 Canada

        3. 5.2.1.3 Mexico

      2. 5.2.2 Europe

        1. 5.2.2.1 Germany

        2. 5.2.2.2 United Kingdom

        3. 5.2.2.3 France

        4. 5.2.2.4 Italy

        5. 5.2.2.5 Spain

        6. 5.2.2.6 Rest of Europe

      3. 5.2.3 Asia-Pacific

        1. 5.2.3.1 China

        2. 5.2.3.2 Japan

        3. 5.2.3.3 India

        4. 5.2.3.4 Australia

        5. 5.2.3.5 South Korea

        6. 5.2.3.6 Rest of Asia-Pacific

      4. 5.2.4 Middle-East and Africa

        1. 5.2.4.1 GCC

        2. 5.2.4.2 South Africa

        3. 5.2.4.3 Rest of Middle-East and Africa

      5. 5.2.5 South America

        1. 5.2.5.1 Brazil

        2. 5.2.5.2 Argentina

        3. 5.2.5.3 Rest of South America

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 Apnea Sciences

      2. 6.1.2 ASF Medical GmbH (Tomed GmbH)

      3. 6.1.3 Fisher & Paykel Healthcare Limited

      4. 6.1.4 Koninklijke Philips NV

      5. 6.1.5 Lear Corporation (AccuMED Corp.)

      6. 6.1.6 Meditas

      7. 6.1.7 Mitsui Chemicals (Whole You Inc.)

      8. 6.1.8 ResMed

      9. 6.1.9 SomnoMed

      10. 6.1.10 The Pure Sleep Company

      11. 6.1.11 Innovative Health Technologies

      12. 6.1.12 GlaxoSmithKline

      13. 6.1.13 Rotech Healthcare

    2. *List Not Exhaustive
  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies, and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Global Anti-Snoring Market market is studied from 2018 - 2026.

The Global Anti-Snoring Market is growing at a CAGR of 10.6% over the next 5 years.

Asia Pacific is growing at the highest CAGR over 2021- 2026.

North America holds highest share in 2020.

Fisher & Paykel Healthcare Limited, Koninklijke Philips NV, Resmed, ASF Medical GmbH (Tomed GmbH), Apnea Sciences are the major companies operating in Global Anti-Snoring Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!